Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

lipoxygenase/infarkt

Link salvestatakse lõikelauale
10 tulemused

Use of 5-lipoxygenase activating protein (FLAP) gene to assess susceptibility for myocardial infarction

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION Myocardial infarction (MI) is one of the most common diagnoses in hospitalized patients in industrialized countries. Myocardial Infarction generally occurs when there is an abrupt decrease in coronary blood flow following a thrombotic occlusion of a coronary artery

Lipoxygenase inhibiting 1-arylalkyl-, 1-arylthio-, and 1-aryloxypyrazole-4,5-diones

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The invention relates to pyrazoledione derivatives, processes for their preparation, their use in the prophylaxis and therapy of diseases of the respiratory tract, inflammations, rheumatism, thromboembolic diseases, ischaemias and infarcts, cardiac arrhythmias and arteriosclerosis, and mixtures of

Bis-S-alkylbenzene derivatives

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION This invention relates to novel bis-S-alkylbenzene derivatives which exert an inhibition effect on lipoxygenase, in particular, 5-lipoxygenase, and to a lipoxygenase inhibitor composition containing the same. BACKGROUND OF THE INVENTION 5-lipoxygenase is an enzyme involved in

Substituted chromans and their use in the treatment of asthma, arthritis and related diseases

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION The present invention is directed to substituted chromans of the formula (I), depicted below, which by inhibiting 5-lipoxygenase enzyme are useful in the prevention or treatment of asthma, arthritis, psoriasis, ulcers, myocardial infarction, stroke and related disease
BACKGROUND OF THE INVENTION The present intention is directed to substituted tetralins, chromans and related compounds of the formula (I), depicted below, which by inhibiting 5-lipoxygenase enzyme and/or blocking leukotriene receptors, are useful in the prevention or treatment of asthma, arthritis,
BACKGROUND OF THE INVENTION The present invention is directed to substituted tetralins, chromans and related compounds of the formula (I), depicted below, which by inhibiting 5-lipoxygenase enzyme and/or blocking leukotriene receptors, are useful in the prevention or treatment of asthma, arthritis,

Substituted tetralins, chromans and related compounds in the treatment of asthma

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION The present invention is directed to substituted tetralins, chromans and related compounds of the formula (I), depicted below, which by inhibiting 5-lipoxygenase enzyme and/or blocking leukotriene receptors, are useful in the prevention or treatment of asthma, arthritis,

Fused phenol derivatives

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
SUMMARY This invention is related to fused phenol derivatives. More particularly, this invention is related to: (1) fused phenol derivatives of the formula (I): ##STR3## wherein all the symbols are the same meaning as hereafter defined, and non-toxic salts thereof and non-toxic acid addition salts

Fused phenol derivatives

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
SUMMARY This invention is related to fused phenol derivatives. More particularly, this invention is related to: (1) fused phenol derivatives of the formula (I): ##STR3## wherein all the symbols are the same meaning as hereafter defined, and non-toxic salts thereof and non-toxic acid addition salts

Bis-imidazolinoamino derivatives as antiallergy compounds

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This invention relates to new chemical compounds which posses valuable therapeutic activity particularly as lipoxygenase and phospholipase C inhibitors and platelet-activating factor receptor antagonists. These compounds possess anti-inflammatory, anti-asthmatic and antiallergic properties and are
Liitu meie
facebooki lehega

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

  • Töötab 55 keeles
  • Taimsed ravimid, mida toetab teadus
  • Maitsetaimede äratundmine pildi järgi
  • Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
  • Lugege oma otsinguga seotud teaduspublikatsioone
  • Otsige ravimtaimi nende mõju järgi
  • Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel

Google Play badgeApp Store badge